NEW YORK (GenomeWeb News) — ProMetic BioSciences has sold CA$3.9 million ($3.4 million) worth of its mimetic ligand affinity adsorbent product to an “existing multinational” client, the company said today.
 
ProMetic Bio, a division of ProMetic Life Sciences, said it will supply the products in the first and second quarters of 2007.
 
Earlier this month, ProMetic said it would develop synthetic ligands for Novartis' vaccine program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.